Tag: Drugs and Pharmaceuticals

SARASOTA, Fla. -- The Sarasota Florida attorney commented after a Philadelphia jury returned a verdict of $70 million against Johnson and Johnson for failing to warn of the risks associated for taking Risperdal. The case involved a sixteen-year-old boy who developed breast from the medication prescribed for attention deficit disorder (ADHD).

NEW YORK, N.Y. /eNewsChannels/ -- NEWS: Weitz and Luxenberg, P.C., announced it is accepting cases of congenital heart defects and cleft facial abnormalities in children whose mothers took the prescription drug Zofran (GlaxoSmithKline) during pregnancy to relieve symptoms of morning sickness.

MADISON, N.J. /eNewsChannels/ -- NEWS Apr 19, 2013: Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license agreement for Bausch + Lomb to commercialize and distribute Paragon's phenylephrine in the United States on an exclusive basis beginning this month.

ATLANTA, Ga. /eNewsChannels/ -- CMI and Pfizer Inc. (NYSE:PFE) will co-present 'Engaging Stakeholders with A Story - 3 Tips to Improve Research Reporting' at the PMRG's upcoming National Annual Conference March 10-12, 2013 in National Harbor, Maryland.

ATLANTA, Ga. /eNewsChannels/ -- CMI Research, a leader in marketing research services and insight, announced today that Beth Thompson has joined as Vice President, Qualitative Research. Thompson brings a 20-year track record of successfully conducting highly complex domestic and global marketing research.

BRIDGEPORT, Conn. /eNewsChannels/ -- In the early 1980's George Coleman, head of Dermedics Laboratories in Bridgeport, Conn., teamed up with the former Keneric Industries to reformulate and market an over-the-counter pharmaceutical product designed to treat the symptoms of hangovers. The product, Dr. Seltzer's Hangover Helper, went on to become the best-selling hangover remedy in the U.S. It was eventually sold to a well-known manufacturer and, after almost 20 years on the market, was discontinued when that manufacturer was sold.

HIGHLAND PARK, N.J. /eNewsChannels/ -- 2012 marks an important milestone for Belvidere Pharmacy. It opened new doors in its new hometown of Highland Park. When owner and President Shara Rudner, R.Ph. took the reins of the business in 1996, it was a typical retail pharmacy stocked with everything from school to surgical supplies. But from the beginning, Belvidere's staff handled requests for compounded, or custom-made, medications from veterinarians, physicians and specialists.

MALVERN, Pa. /eNewsChannels/ -- Reaction Biology Corporation ('RBC') today announced the publication in Nature Biotechnology, of the largest kinase profiling data set in the public domain, disclosing previously unknown kinase inhibition relationships. The data set was compiled from over 100,000 independent activity assays performed with RBC's proprietary HotSpot(SM) technology.

MALVERN, Pa. /eNewsChannels/ -- Reaction Biology Corporation ('RBC'), a leading contract research organization providing drug discovery services in epigenetics, today announced the rollout of a new product line, recombinant proteins for epigenetic research. RBC's initial offerings will emphasize the histone methyltransferases (HMTs), including exclusive targets for which there has been no previous commercial source.

SAN MARINO, Calif. /eNewsChannels/ -- Epeius Bio announced today that the U.S. FDA has granted Phase 3 status for Company's lead anti-cancer agent, Rexin-G, the first, and so far only, targeted gene delivery system developed to seek-out and destroy metastatic cancer.